Adaptation of multidisciplinary meeting decisions in a medical oncology department during the COVID epidemic in a less affected region of France: a prospective analysis from Bordea...

por Heraudet, Luc, Domblides, Charlotte, Daste, Amaury, Gross-Goupil, Marine, Ravaud, Alain
Publicado 2020

Metastatic non-muscle invasive bladder cancer with meningeal carcinomatosis: case report of an unexpected response

por Teyssonneau, Diego, Daste, Amaury, Dousset, Vincent, Hoepffner, Jean-Luc, Ravaud, Alain, Gross-Goupil, Marine
Publicado 2017

Optimal management of renal cell carcinoma in the elderly: a review

por Quivy, Amandine, Daste, Amaury, Harbaoui, Asma, Duc, Sophie, Bernhard, Jean-Christophe, Gross-Goupil, Marine, Ravaud, Alain
Publicado 2013

Management of Immune Checkpoint Inhibitor Toxicities

por Durrechou, Quentin, Domblides, Charlotte, Sionneau, Baptiste, Lefort, Felix, Quivy, Amandine, Ravaud, Alain, Gross-Goupil, Marine, Daste, Amaury
Publicado 2020

Effect of prior immunotherapy on the efficacy of chemotherapy in advanced non‐small cell lung cancer: A retrospective study

por Heraudet, Luc, Delon, Tara, Veillon, Rémi, Vergnenègre, Charlotte, Lepetit, Hélène, Daste, Amaury, Ravaud, Alain, Zysman, Maéva, Domblides, Charlotte
Publicado 2022

Efficacy of second-line chemotherapy or immune checkpoint inhibitors for patients with a prolonged objective response (≥ 6 months) after first-line therapy for recurrent or metasta...

por Vienne, Agathe, Collet, Laetitia, Chevalier, Thomas, Borel, Christian, Tardy, Magalie, Huguet, Florence, Richard, Sandrine, Salas, Sebastien, Saada-Bouzid, Esma, Fayette, Jerome, Daste, Amaury
Publicado 2023

Bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1, in advanced squamous cell carcinoma of the head and neck: results from a phase I cohort

por Cho, Byoung Chul, Daste, Amaury, Ravaud, Alain, Salas, Sébastien, Isambert, Nicolas, McClay, Edward, Awada, Ahmad, Borel, Christian, Ojalvo, Laureen S, Helwig, Christoph, Rolfe, P Alexander, Gulley, James L, Penel, Nicolas
Publicado 2020

Cetuximab combined with paclitaxel or paclitaxel alone for patients with recurrent or metastatic head and neck squamous cell carcinoma progressing after EXTREME

por Chevalier, Thomas, Daste, Amaury, Saada‐Bouzid, Esmaa, Loundou, Anderson, Peyraud, Florent, Lambert, Tiphaine, Le Tourneau, Christophe, Peyrade, Frédéric, Dupuis, Charlotte, Alfonsi, Marc, Fayette, Jérôme, Reure, Juliette, Huguet, Florence, Fakhry, Nicolas, Toullec, Clémence, Salas, Sébastien
Publicado 2021

Plasma galectins and metabolites in advanced head and neck carcinomas: evidence of distinct immune characteristics linked to hypopharyngeal tumors

por Tran, Bao-Tram Thi, Gelin, Aurore, Durand, Sylvère, Texier, Matthieu, Daste, Amaury, Toullec, Clémence, Benihoud, Karim, Breuskin, Ingrid, Gorphe, Philippe, Garic, Florence, Brenner, Catherine, Le Tourneau, Christophe, Fayette, Jérôme, Niki, Toshiro, David, Muriel, Busson, Pierre, Even, Caroline
Publicado 2022

Avelumab for platinum-ineligible/refractory recurrent and/or metastatic squamous cell carcinoma of the head and neck: phase Ib results from the JAVELIN Solid Tumor trial

por Guigay, Joël, Lee, Keun-Wook, Patel, Manish R, Daste, Amaury, Wong, Deborah J, Goel, Sanjay, Gordon, Michael S, Gutierrez, Martin, Balmanoukian, Ani, Le Tourneau, Christophe, Mita, Alain, Vansteene, Damien, Keilholz, Ulrich, Schöffski, Patrick, Grote, Hans Juergen, Zhou, Dongli, Bajars, Marcis, Penel, Nicolas
Publicado 2021

Immune checkpoint inhibitor rechallenge in patients who previously experienced immune-related inflammatory arthritis: a multicentre observational study

por Ladouceur, Alexandra, Barnetche, Thomas, Mouterde, Gael, Tison, Alice, Bitoun, Samuel, Prey, Sorilla, Dutriaux, Caroline, Gerard, Emilie, Pham-Ledard, Anne, Beylot-Barry, Marie, Zysman, Maeva, Veillon, Rémi, Domblides, Charlotte, Daste, Amaury, Gross-Goupil, Marine, Sionneau, Baptiste, Lefort, Felix, Larroquette, Mathieu, Richez, Christophe, Truchetet, Marie-Elise, Schaeverbeke, Thierry, Kostine, Marie
Publicado 2023

Nivolumab Plus Ipilimumab Versus EXTREME Regimen as First-Line Treatment for Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck: The Final Results of CheckMate 651

por Haddad, Robert I., Harrington, Kevin, Tahara, Makoto, Ferris, Robert L., Gillison, Maura, Fayette, Jerome, Daste, Amaury, Koralewski, Piotr, Zurawski, Bogdan, Taberna, Miren, Saba, Nabil F., Mak, Milena, Kawecki, Andrzej, Girotto, Gustavo, Alvarez Avitia, Miguel Angel, Even, Caroline, Toledo, Joaquin Gabriel Reinoso, Guminski, Alexander, Müller-Richter, Urs, Kiyota, Naomi, Roberts, Mustimbo, Khan, Tariq Aziz, Miller-Moslin, Karen, Wei, Li, Argiris, Athanassios
Publicado 2023